Stock listing
Onkure Therapeutics, Inc.
Selected listing: OKUR · NASDAQ · USD · US
Onkure Therapeutics, Inc. (NASDAQ:OKUR), Health Technology. Latest release Aug 31, 2026: OnKure Therapeutics to Participate in the Morgan Stanley Global…
- Ticker
- NASDAQ:OKUR
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Onkure Therapeutics, Inc.
Onkure Therapeutics, Inc. is a public company traded under the ticker OKUR in the American market. The company's mission is to address unmet medical needs through its research and development efforts.
Latest news from Onkure Therapeutics, Inc.
OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference
August 31, 2026
OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
August 4, 2026
OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026
July 1, 2026
OnKure Therapeutics Reports First Quarter 2026 Financial Results
May 5, 2026
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies
March 26, 2026
Research Onkure Therapeutics, Inc.
Onkure Therapeutics, Inc. company profile
View the public company page for Onkure Therapeutics, Inc. on 6ix.
Onkure Therapeutics, Inc. news
Read company news and market updates connected to Onkure Therapeutics, Inc..
Onkure Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Onkure Therapeutics, Inc..